COLGATE PALMOLIVE CO(CL)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #786 of 2,961 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CL Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for COLGATE PALMOLIVE CO (CL), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores CL at 61.3/100 on a 32-signal composite quality model, placing it at rank #786 of 2,961 stocks — the top half of the AI-ranked universe. CL scores in the top quartile across revenue scale (92.8), balance sheet strength (88.8). Areas of concern include revenue growth (34.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), COLGATE PALMOLIVE CO reports quarterly revenue of $5.4B, net income of $693.0M, an operating margin of 18.9%. Top institutional holders of CL by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CL trades on the NYSE exchange and files with the SEC under CIK 21665. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COLGATE PALMOLIVE CO directly from SEC EDGAR. COLGATE PALMOLIVE CO's 13F Pro composite quality score has ranged between 60 and 78 since 2021, currently 61.3 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.
What's Driving CL's Business? Latest 10-Q Breakdown
✓ 48/48 datapoints verifiedAI-extracted from COLGATE PALMOLIVE CO's 10-Q filed 2026-07-31 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net sales rose 4.9% to $5,361M on 2.4% organic growth, but $129M of Strategic Growth and Productivity Program charges cut operating profit 6% to $1,016M.
Biggest Revenue Drivers
Volume growth of 2.6%, net selling price increases of 2.8% and positive foreign exchange of 8.4%; organic growth led by Mexico, Brazil and Argentina.
Net selling price increases of 3.9% and positive foreign exchange of 0.6%, partially offset by volume declines of 1.2%; growth in therapeutic and wellness categories.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q2 2026
$5.4B
Net Income
Q2 2026
$693.0M
Free Cash Flow
Q2 2026
$867.0M
Operating Margin
Q2 2026
18.9%
ROIC
Q2 2026
50.4%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+1.4% YoYNet Income
-26.2% YoYOperating Income
-22.5% YoYEPS (Diluted)
-25.1% YoYTotal Assets
+1.8% YoYTotal Debt
+12.8% YoYOp. Cash Flow
+2.2% YoYFree Cash Flow
+2.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $20.38B +1.4% | $20.10B +3.3% | $19.46B +8.3% | $17.97B +3.1% | $17.42B +5.8% | $16.47B |
| Net Income | $2.13B -26.2% | $2.89B +25.6% | $2.30B +28.9% | $1.78B -17.6% | $2.17B -19.6% | $2.69B |
| Operating Income | $3.31B -22.5% | $4.27B +7.1% | $3.98B +37.7% | $2.89B -13.2% | $3.33B -14.2% | $3.88B |
| EPS (Diluted) | $2.63 -25.1% | $3.51 +26.7% | $2.77 +30.0% | $2.13 -16.5% | $2.55 -18.8% | $3.14 |
| Total Assets | $16.33B +1.8% | $16.05B -2.1% | $16.39B +4.2% | $15.73B +4.6% | $15.04B -5.5% | $15.92B |
| Total Debt | $8.95B +12.8% | $7.94B -3.6% | $8.24B -5.9% | $8.76B +21.5% | $7.21B -1.9% | $7.34B |
| Operating Cash Flow | $4.20B +2.2% | $4.11B +9.7% | $3.75B +46.5% | $2.56B -23.1% | $3.33B -10.6% | $3.72B |
| Free Cash Flow | $3.63B +2.5% | $3.55B +16.6% | $3.04B +63.4% | $1.86B -32.6% | $2.76B -16.7% | $3.31B |
Get alerted when CL's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for COLGATE PALMOLIVE CO including:
Top Institutional Holders of CL
BlackRock, Inc.
$6.4B69,915,472 shVANGUARD CAPITAL MANAGEMENT LLC
$4.8B52,246,333 shSTATE STREET CORP
$4.3B47,020,966 shPRICE T ROWE ASSOCIATES INC /MD/
$2.6B27,909,525 shVANGUARD PORTFOLIO MANAGEMENT LLC
$2.2B24,021,137 shGEODE CAPITAL MANAGEMENT, LLC
$2.1B23,144,319 shMORGAN STANLEY
$2.0B22,072,925 shBank of New York Mellon Corp
$1.2B13,532,417 shDEUTSCHE BANK AG\
$1.1B11,751,973 shNORGES BANK
$888.0M9,686,029 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $6.4B | 69,915,472 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.8B | 52,246,333 |
| STATE STREET CORP | $4.3B | 47,020,966 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $2.6B | 27,909,525 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.2B | 24,021,137 |
| GEODE CAPITAL MANAGEMENT, LLC | $2.1B | 23,144,319 |
| MORGAN STANLEY | $2.0B | 22,072,925 |
| Bank of New York Mellon Corp | $1.2B | 13,532,417 |
| DEUTSCHE BANK AG\ | $1.1B | 11,751,973 |
| NORGES BANK | $888.0M | 9,686,029 |
Companies Similar to CL
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
PEPSICO INC
PROCTER & GAMBLE Co
Mondelez International, Inc.
HERSHEY CO
COCA COLA CO
MCCORMICK & CO INC
ALTRIA GROUP, INC.
Corteva, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Consumer Staples Companies
View all Consumer Staples →Put CL on your watchlist
Track score changes the day COLGATE PALMOLIVE CO files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CL a good stock to buy?
13F Pro's AI-powered analysis of COLGATE PALMOLIVE CO (CL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CL are available on the CL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CL is classified as a large company.
Which hedge funds own CL?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of COLGATE PALMOLIVE CO's investment landscape.